医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
KYMR · Kymera Therapeutics, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Kymera Therapeutics, Inc.（KYMR）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $28.6M；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-01。
买入 Bought—
卖出 Sold$28.6M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-01 | Mainolfi Nello Chief Executive Officer, Director | 卖出 Sell | 30,000 | $113.80 | $3.4M | SEC |
| 2026-09-04 | Adams Brian Chief Legal Officer | 卖出 Sell | 6,371 | $116.83 | $744K | SEC |
| 2026-07-07 | Mainolfi Nello Chief Executive Officer, Director | 卖出 Sell | 50,000 | $119.00 | $6.0M | SEC |
| 2026-07-01 | Goodman Noah Chief Business Officer | 卖出 Sell | 3,389 | $114.29 | $387K | SEC |
| 2026-06-30 | Jacobs Bruce N. Chief Financial Officer | 卖出 Sell | 77,109 | $114.96 | $8.9M | SEC |
| 2026-07-01 | Mainolfi Nello Chief Executive Officer, Director | 卖出 Sell | 80,000 | $115.29 | $9.2M | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-01 | Mainolfi Nello Officer, Director | 30,000 | $3.4M | 10b5-1 |
| 2026-09-04 | Adams Brian Officer | 6,371 | $747K | |
| 2026-09-02 | Chadwick Jeremy G Officer | 10,879 | $1.3M | 10b5-1 |
| 2026-07-07 | Mainolfi Nello Officer, Director | 50,000 | $6.0M | 10b5-1 |
| 2026-07-01 | Mainolfi Nello Officer, Director | 80,000 | $9.1M | 10b5-1 |
| 2026-07-01 | Goodman Noah Officer | 3,389 | $389K | 10b5-1 |
内部人 Insiders
Mainolfi Nello、Adams Brian、Goodman Noah、Jacobs Bruce N.